Skip to main content
Contact Us
Subscribe
E-Edition
72°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc
(TSX:
BHC
)
8.950
+0.360 (+4.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bausch Health Companies Inc
< Previous
1
2
3
Next >
U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
November 01, 2023
Via
ACCESSWIRE
Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
October 26, 2023
Via
ACCESSWIRE
FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
October 20, 2023
Via
ACCESSWIRE
New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
October 17, 2023
Via
ACCESSWIRE
Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
October 12, 2023
Via
ACCESSWIRE
Salix Pharmaceuticals Partners with Bellamy Young
October 04, 2023
Via
ACCESSWIRE
League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease
September 21, 2023
Via
ACCESSWIRE
Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients
July 27, 2023
Via
ACCESSWIRE
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
July 11, 2023
Via
ACCESSWIRE
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
October 10, 2023
Via
ACCESSWIRE
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
September 29, 2023
Via
ACCESSWIRE
Bausch Health Announces CFO Transition Plan
September 18, 2023
Via
ACCESSWIRE
New Bausch Health Treatment PrUCERIS(R) (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in Adults
September 12, 2023
Via
ACCESSWIRE
Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023
June 19, 2023
Via
ACCESSWIRE
Bausch Health Announces 2023 Annual Meeting of Shareholder Results
May 17, 2023
Via
ACCESSWIRE
Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023
May 08, 2023
Via
ACCESSWIRE
Bausch Health Announces First-Quarter 2023 Results
May 04, 2023
Via
ACCESSWIRE
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
September 11, 2023
Via
ACCESSWIRE
Bausch Health's Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA(R)
September 06, 2023
Via
ACCESSWIRE
Bausch Health Announces Second-Quarter 2023 Results, Other Key Updates From the Quarter, and Raises Full-Year 2023 Revenue Outlook
August 03, 2023
Via
ACCESSWIRE
Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
July 13, 2023
Via
ACCESSWIRE
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel
May 01, 2023
Via
ACCESSWIRE
OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference
July 07, 2023
Via
ACCESSWIRE
Bausch Health Enters Into $600 Million Financing Facility With KKR
July 07, 2023
Via
ACCESSWIRE
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
June 30, 2023
Via
ACCESSWIRE
Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration
June 06, 2023
Via
ACCESSWIRE
New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis
May 18, 2023
Via
ACCESSWIRE
U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
May 17, 2023
Via
ACCESSWIRE
Bausch Health Observes Mental Health Awareness Month
May 10, 2023
Via
ACCESSWIRE
New Artificial Intelligence Tool Can Diagnose Colon Cancer
May 03, 2023
A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and...
Via
PressReach
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.